Cortical spreading depolarization and ketamine:a short systematic review

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTELLES, Joao Paulo Mota
dc.contributor.authorWELLING, Leonardo Christiaan
dc.contributor.authorCOELHO, Antonio Carlos Samaia da Silva
dc.contributor.authorRABELO, Nicollas Nunes
dc.contributor.authorTEIXEIRA, Manoel Jacobsen
dc.contributor.authorFIGUEIREDO, Eberval Gadelha
dc.date.accessioned2021-06-17T13:53:32Z
dc.date.available2021-06-17T13:53:32Z
dc.date.issued2021
dc.description.abstractIntroduction. - Cortical spreading depolarization (SD) describes pathological waves characterized by an almost complete sustained depolarization of neurons and astrocytes that spreads throughout the cortex. In this study, we carried out a qualitative review of all available evidence, clinical and preclinical, on the use of ketamine in SD. Methods. - We performed a systematic review of Medline, with no restrictions regarding publishing date or language, in search of articles reporting the use of ketamine in SD. The search string was composed of ""ketamine,"" ""spreading,"" ""depolarization,"" and ""depression"" in both (AND) and (OR) combinations. Results. - Twenty studies were included in the final synthesis. Many studies showed that ketamine effectively blocks SD in rats, swine, and humans. The first prospective randomized trial was published in 2018. Ten patients with severe traumatic brain injury or subarachnoid hemorrhage were enrolled, and ketamine showed a significant, dose-dependent effect on the reduction of SD. Conclusion. - The available evidence from preclinical studies is helping to translate the role of ketamine in blocking spreading depolarizations to clinical practice, in the settings of migraine with aura, traumatic brain injury, subarachnoid hemorrhage, and hemorrhagic and ischemic stroke. More randomized controlled trials are needed to determine whether interrupting the ketamine-blockable SDs effectively leads to an improvement in outcome and to assess the real occurrence of adverse effects.eng
dc.description.indexMEDLINEeng
dc.identifier.citationNEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, v.51, n.2, p.145-151, 2021
dc.identifier.doi10.1016/j.neucli.2021.01.004
dc.identifier.eissn1769-7131
dc.identifier.issn0987-7053
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/40725
dc.language.isoeng
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIEReng
dc.relation.ispartofNeurophysiologie Clinique-Clinical Neurophysiology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIEReng
dc.subjectCortical spreading depressioneng
dc.subjectCritical careeng
dc.subjectKetamineeng
dc.subjectN-methyl-D-aspartateeng
dc.subjectReceptorseng
dc.subject.wosClinical Neurologyeng
dc.subject.wosNeuroscienceseng
dc.subject.wosPhysiologyeng
dc.titleCortical spreading depolarization and ketamine:a short systematic revieweng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalWELLING, Leonardo Christiaan:Univ Estadual Ponta Grossa, Dept Neurol Surg, Ponta Grosso, Brazil
hcfmusp.citation.scopus10
hcfmusp.contributor.author-fmusphcJOAO PAULO MOTA TELLES
hcfmusp.contributor.author-fmusphcANTONIO CARLOS SAMAIA DA SILVA COELHO
hcfmusp.contributor.author-fmusphcNICOLLAS NUNES RABELO
hcfmusp.contributor.author-fmusphcMANOEL JACOBSEN TEIXEIRA
hcfmusp.contributor.author-fmusphcEBERVAL GADELHA FIGUEIREDO
hcfmusp.description.beginpage145
hcfmusp.description.endpage151
hcfmusp.description.issue2
hcfmusp.description.volume51
hcfmusp.origemWOS
hcfmusp.origem.pubmed33610431
hcfmusp.origem.scopus2-s2.0-85101057773
hcfmusp.origem.wosWOS:000639255400005
hcfmusp.publisher.cityISSY-LES-MOULINEAUXeng
hcfmusp.publisher.countryFRANCEeng
hcfmusp.relation.referenceAfridi SK, 2013, NEUROLOGY, V80, P642, DOI 10.1212/WNL.0b013e3182824e66eng
hcfmusp.relation.referenceAMEMORI T, 1990, BRAIN RES, V519, P351, DOI 10.1016/0006-8993(90)90101-Geng
hcfmusp.relation.referenceCarlson AP, 2019, J NEUROSURG, V131, P1773, DOI 10.3171/2018.7.JNS181478eng
hcfmusp.relation.referenceCarlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665eng
hcfmusp.relation.referenceDel-Bel EA, 2000, BRAZ J MED BIOL RES, V33, P521, DOI 10.1590/S0100-879X2000000500006eng
hcfmusp.relation.referenceDijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2eng
hcfmusp.relation.referenceDRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-Eeng
hcfmusp.relation.referenceDreier JP, 2007, EXP BIOL MED, V232, P204eng
hcfmusp.relation.referenceDreier JP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00373eng
hcfmusp.relation.referenceDreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147eng
hcfmusp.relation.referenceDreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004eng
hcfmusp.relation.referenceDreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303eng
hcfmusp.relation.referenceDreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333eng
hcfmusp.relation.referenceDreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102eng
hcfmusp.relation.referenceGORELOVA NA, 1987, ELECTROEN CLIN NEURO, V66, P440, DOI 10.1016/0013-4694(87)90213-6eng
hcfmusp.relation.referenceHartings JA, 2003, J NEUROSCI, V23, P11602eng
hcfmusp.relation.referenceHartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476eng
hcfmusp.relation.referenceHartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495eng
hcfmusp.relation.referenceHartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5eng
hcfmusp.relation.referenceHartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]eng
hcfmusp.relation.referenceHERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0eng
hcfmusp.relation.referenceHertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152eng
hcfmusp.relation.referenceHimmelseher S, 1996, ANESTH ANALG, V83, P505, DOI 10.1097/00000539-199609000-00011eng
hcfmusp.relation.referenceHimmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5Beng
hcfmusp.relation.referenceHOFFMAN WE, 1992, ANESTHESIOLOGY, V76, P755, DOI 10.1097/00000542-199205000-00014eng
hcfmusp.relation.referenceKamp J, 2019, EXPERT OPIN DRUG MET, V15, P1033, DOI 10.1080/17425255.2019.1689958eng
hcfmusp.relation.referenceKaube H, 2000, NEUROLOGY, V55, P139, DOI 10.1212/WNL.55.1.139eng
hcfmusp.relation.referenceKazemi H, 2014, IRAN J CHILD NEUROL, V8, P6eng
hcfmusp.relation.referenceKruger H, 1999, NEUROREPORT, V10, P2651eng
hcfmusp.relation.referenceLauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191eng
hcfmusp.relation.referenceLavender E, 2020, BEHAV BRAIN RES, V390, DOI 10.1016/j.bbr.2020.112631eng
hcfmusp.relation.referenceLeao AAP, 1944, J NEUROPHYSIOL, V7, P359eng
hcfmusp.relation.referenceLEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409eng
hcfmusp.relation.referenceLuckl J, 2018, BRAIN, V141, P1734, DOI 10.1093/brain/awy102eng
hcfmusp.relation.referenceMajor S, 2020, GEROSCIENCE, V42, P57, DOI 10.1007/s11357-019-00142-7eng
hcfmusp.relation.referenceMARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7eng
hcfmusp.relation.referenceMARTIN H, 1994, NEUROSCI LETT, V180, P285, DOI 10.1016/0304-3940(94)90540-1eng
hcfmusp.relation.referenceMIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027eng
hcfmusp.relation.referenceMuller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9eng
hcfmusp.relation.referenceMurphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008eng
hcfmusp.relation.referenceNagata S, 2006, SURG NEUROL, V66, P50, DOI 10.1016/j.surneu.2005.12.017eng
hcfmusp.relation.referencePacheco JM, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0070-19.2019eng
hcfmusp.relation.referencePetzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0eng
hcfmusp.relation.referenceProescholdt M, 2001, BRAIN RES, V904, P245, DOI 10.1016/S0006-8993(01)02465-9eng
hcfmusp.relation.referenceRANSOM BR, 1990, NEUROLOGY, V40, P1399, DOI 10.1212/WNL.40.9.1399eng
hcfmusp.relation.referenceRASHIDYPOUR A, 1995, BRAIN RES, V693, P64, DOI 10.1016/0006-8993(95)00692-Jeng
hcfmusp.relation.referenceReeker W, 2000, CAN J ANAESTH, V47, P572, DOI 10.1007/BF03018950eng
hcfmusp.relation.referenceReinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007eng
hcfmusp.relation.referenceSakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303eng
hcfmusp.relation.referenceSanchez-Porras R, 2017, J CEREBR BLOOD F MET, V37, P1720, DOI 10.1177/0271678X16646586eng
hcfmusp.relation.referenceSanchez-Porras R, 2014, NEUROPHARMACOLOGY, V84, P52, DOI 10.1016/j.neuropharm.2014.04.018eng
hcfmusp.relation.referenceSantos E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2711-3eng
hcfmusp.relation.referenceSchiefecker AJ, 2015, NEUROCRIT CARE, V22, P293, DOI 10.1007/s12028-014-0050-4eng
hcfmusp.relation.referenceSchoknecht K, 2021, J CEREBR BLOOD F MET, V41, P413, DOI 10.1177/0271678X20915801eng
hcfmusp.relation.referenceSHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001eng
hcfmusp.relation.referenceSomjen GG, 2001, PHYSIOL REV, V81, P1065eng
hcfmusp.relation.referenceSueiras Maria, 2021, J Clin Neurophysiol, V38, P47, DOI 10.1097/WNP.0000000000000648eng
hcfmusp.relation.referenceTong CK, 2000, J NEUROPHYSIOL, V84, P2449eng
hcfmusp.relation.referenceVERHAEGEN M, 1992, BRAIN RES, V581, P153, DOI 10.1016/0006-8993(92)90355-Deng
hcfmusp.relation.referenceZanos P, 2018, PHARMACOL REV, V70, P621, DOI 10.1124/pr.117.015198eng
hcfmusp.relation.referenceZheng ZL, 2020, ACTA NEUROCHIR SUPPL, V127, P97, DOI 10.1007/978-3-030-04615-6_16eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication96904c27-1d13-4864-b93c-18bd7ed7adb8
relation.isAuthorOfPublication6b25b9eb-5d44-41bd-b696-75bc3a5effd3
relation.isAuthorOfPublication3787de9a-e85e-4641-ab8f-97bb1240e01a
relation.isAuthorOfPublicationb665cf91-624e-4b90-92bc-9df755eeeaaf
relation.isAuthorOfPublicationb4a34dbe-d274-4cdd-8485-5c8e561da3a4
relation.isAuthorOfPublication.latestForDiscovery96904c27-1d13-4864-b93c-18bd7ed7adb8
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_TELLES_Cortical_spreading_depolarization_and_ketaminea_short_systematic_review_2021.PDF
Tamanho:
850.91 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/62
Artigos e Materiais de Revistas Científicas - ODS/03